Healio

Left bundle branch area pacing via leadless conduction system device achievable

Please provide your email address to receive an email when new articles are posted on . Left bundle branch pacing was achieved for the first time via leadless pacemaker. Implantation failure rate was ...
TCTMD

Left Bundle Branch Area Pacing May Lessen Arrhythmias in CRT Patients

PHILADELPHIA, PA—For patients treated with cardiac resynchronization therapy, use of left bundle branch area pacing (LBBAP) appears to lower arrhythmic risk compared with conventional biventricular ...
Business Wire

EBR Systems’ WiSE CRT System Demonstrates Technical Feasibility of Leadless Left Bundle Branch Area Pacing for Cardiac Resynchronization

SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced the publication of a case report demonstrating ...
MassDevice

Biotronik kicks off study of leadless pacemaker, announces first commercial implant of LBBAP lead

The placement device for the LivIQ leadless pacemaker. [Image courtesy of Biotronik] Biotronik today announced the initiation ...
Nasdaq

Abbott Completes In-human Left Bundle Branch Area Pacing Procedures Using AVEIR CSP Pacemaker

(RTTNews) - Abbott (ABT) announced the successful completion of the world's first in-human leadless left bundle branch area pacing procedures using the company's investigational AVEIR Conduction ...
MassDevice

Medtronic wins expanded FDA approval for OmniaSecure for conduction pacing

Medtronic announced today that it received FDA approval for an expanded indication for its OmniaSecure defibrillation lead.
Business Wire

World’s First Leadless Left Bundle Branch Area Pacing Implant Utilizing EBR Systems’ WiSE CRT System

SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced that Professor Pascal Defaye, Head of Rhythmology ...
Medical Device and Diagnostic Industry (MD+DI)

Medtronic’s Tiny Defibrillation Lead Packs a Big Punch

Medtronic snagged FDA approval for an expanded indication for its OmniaSecure defibrillation lead. Check out why this tiny ...

Medtronic’s OmniaSecure defibrillation lead earns expanded FDA indication

The OmniaSecure lead gained the first U.S. approval for placement in the heart’s left bundle branch area, to help activate ...

Medtronic OmniaSecure™ defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) ...
The American Journal of Managed Care

Left Bundle-Branch Pacing Reduces Heart Failure Hospitalization vs Biventricular Pacing

Multicenter randomized trial (n=200) assigned LBBP versus BiVP for CRT in LBBB with LVEF ≤35%, using time to death or HF hospitalization as primary endpoint. Event rates favored LBBP, reducing death ...

Medtronic plc: Medtronic OmniaSecure defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing

Built for high reliability, world's only lumenless defibrillation lead approved for placement in the left bundle branch area GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc ...